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 The prevalence of metabolic syndrome continues to 
increase at an alarming rate worldwide. Insulin resistance 
(IR) is highly associated with central obesity, and, by sig-
nifi cantly increasing the risk of developing type 2 diabetes 
and cardiovascular disease, poses a great problem to hu-
man health. However, current therapeutics for IR are pri-
marily limited to weight loss and bariatric surgery and are 
not effective for all patients. To provide alternative thera-
pies, it is essential to understand the molecular mecha-
nisms underlying IR. Adipocytes play a central role in 
regulating whole body metabolism, mainly by secreting 
key hormones and cytokines, as well as lipids. The func-
tions of adipocytes are affected in IR, leading to increased 
infl ammation, dysregulation of lipid metabolism, and 
changes in the adipocyte state ( 1, 2 ). 
 White adipose tissues (WATs) are frequently separated 
into two different types: subcutaneous and visceral. Recent 
studies show that visceral WAT is strongly associated with 
IR, and its tissue mass is an independent risk factor for 
many metabolic diseases ( 3–5 ). In contrast, subcutaneous 
WAT is important for increasing insulin sensitivity and has 
been shown to be metabolically protective ( 6, 7 ). Thus, 
understanding the functional and developmental differ-
ences between visceral and subcutaneous adipocytes in 
insulin-resistant animals may provide insight into restoring 
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were pooled from either six C57BL/6J mice or two db/db mice. 
WAT was excised from the different fat depots in the mice, fi nely 
minced, and digested with collagenase type I (1 mg collagenase/
ml of HEPES buffer; 3 ml/g of tissue) at 37°C for 35–40 min, fi l-
tered to exclude large debris, and singly isolated cells were col-
lected. The cells were separated into the adipocyte (supernatant) 
and SVC fractions (pellet) by spinning cells at 150–200 relative 
centrifugal force (RCF) for 3 min . Each fraction was rinsed three 
times in PBS with 3% BSA. The SVC fraction, which contained 
preadipocytes, was plated in culture medium (DMEM with 10% 
calf serum, 100 U/ml penicillin/streptomycin, and 1   g/ml of 
amphotericin B) for 4 h and then washed with culture medium 
to remove cell debris and nonadherent cells, thus enriching for 
preadipocytes which adhere well to the culture surface. Cells 
were further grown in culture for one to two passages before per-
forming experiments. Mature adipocytes were resuspended in 
buffer A [10 mM HEPES (pH 7.9), 1.5 MgCl 2 , 10 ml KCl, 1 mM 
PMSF, and protease inhibitor (Roche)], and were used immedi-
ately to isolate nuclear proteins. 
 Cell culture 
 OP9 cells were grown following previously published protocols 
( 8, 9 ). Briefl y, cells were grown in MEM  with L-glutamine, 20% 
FBS, and 100 U/ml penicillin/streptomycin. To determine the 
effect of TNF  on insulin sensitivity, OP9 preadipocytes were 
treated with 5 ng/ml TNF  (Sigma-Aldrich T7539) or water 
(control) for 24 h. To determine the effect of PA on insulin sen-
sitivity, 250 mM PA (Sigma-Aldrich P9767) was fi rst dissolved in 
95% ethanol and mixed with 10% fatty acid-free BSA (Sigma-Aldrich 
A8806) in MEM  medium at a fi nal concentration of 5 mM. The 
5 mM mixture was then incubated at 37°C for 1 h to form PA-BSA 
complexes. Then the 5 mM mixture of PA-BSA complexes was 
diluted 10-fold in MEM  and applied to the cells for 24 h. For 
combined TNF  and PA treatment, cells were treated with both 
5 ng/ml TNF  and 0.5 mM PA for 24 h. For the PA or TNF  +PA 
treatments, treatment with 3.8% BSA-ethanol complexes was used 
as the control. 
 To determine the effect of TNF  or PA on adipogenesis, OP9 
cells were plated at 100% confl uency and treated by adding 
TNF  , PA, TNF  + PA, or the appropriate control to MDI me-
dium. MDI medium consists of MEM  containing 10% FBS, 
100 U/ml penicillin/streptomycin, 0.5 mM isobutyl-methylxanthine, 
1   M dexamethasone, and 175   M insulin. After 48 h, the me-
dium was replaced with insulin medium (MEM  containing 10% 
FBS, 100 U/ml penicillin/streptomycin, and 175   M insulin) to 
which TNF  , PA, TNF  +PA, or the appropriate control had been 
added. Cells were fully differentiated 4 days after the addition of 
MDI medium. To measure phospho-AKT (pAKT) levels, cells 
were starved in 0.5% FBS in MEM  for 4 h, stimulated with 1   M 
insulin for 10 min, and then fi xed in preparation for immunocy-
tochemistry analysis . 
 Sample preparation for SRM-MS 
 To isolate nuclei from OP9 cells, cells were rinsed in PBS and 
dounced through 30 gauge needles in buffer A to break open the 
cells. The cell lysate was then centrifuged at 2,500 RCF for 10 min 
at 4°C to pellet the nuclei. To isolate nuclei from primary adipo-
cytes, cells isolated and resuspended in buffer A were broken 
open using a glass-glass dounce homogenizer and centrifuged at 
40,000 RCF for 45 min at 4°C over a 0.5–1.25 M sucrose gradient. 
Isolated nuclei were rinsed twice and pelleted in buffer A by cen-
trifuging at 2,500 RCF for 10 min at 4°C. Nuclear pellets were 
resuspended in a high salt buffer consisting of 20 mM HEPES 
(pH 7.9), 25% v/v glycerol, 450 mM KCl, 1.5 mM MgCl 2 , 0.2 mM 
EDTA, 1 mM DTT, 1 mM PMSF, and EDTA-free complete protease 
systemic insulin sensitivity by converting visceral adipo-
cytes to subcutaneous-like adipocytes. 
 We hypothesized that functional distinctions between 
different types of adipocytes could be discerned by profi l-
ing the expression levels of a group of nuclear proteins 
that are important for differentiation or gene regulation. 
Here, we isolated visceral (epididymal) and subcutaneous 
(inguinal) adipocytes from insulin-resistant Lepr(db/db) 
mice and control C57BL/6J mice and quantifi ed expres-
sion levels of nuclear proteins in these primary adipocytes 
using our novel approach of selected reaction monitoring 
MS (SRM-MS). This approach provides quantifi cation of 
up to hundreds of proteins simultaneously and requires a 
fraction of the protein that would be needed for the equiv-
alent protein quantifi cation by Western blot. We found 
that many proteins that were differentially expressed in 
these adipocytes affected adipogenesis. We then compared 
the protein abundance profi les from primary stromal vas-
cular cells (SVCs), which are enriched for preadipocytes, 
to different cell culture models of IR generated by treat-
ing OP9 cells with IR-inducing compounds. The results 
showed that the nuclear protein profi le of db/db visceral 
SVCs is most similar to that of OP9 preadipocytes treated 
with both TNF  and palmitate (PA). Together our study 
introduces a targeted proteomics approach that can be 
applied to profi le and correlate different types of insulin-
resistant adipocytes and preadipocytes, both from primary 
adipose tissue depots and from cell culture. Under-
standing the molecular mechanisms underlying adipocyte 
dysfunction in insulin-resistant animals is important to 
enable the development of more targeted therapeutics to 
treat IR. 
 MATERIALS AND METHODS 
 Glucose and insulin tolerance tests 
 Nine-week-old C57BL/6J (control) and db/db male mice 
were purchased from Jackson Laboratory and housed in the ani-
mal facility at Stanford University or at the Veterans Administra-
tion Palo Alto Health Care System until they were 10 weeks old. 
The db/db and control mice were in the same genetic back-
ground. All animal studies were approved by the Institutional 
Animal Care and Use Committees at Stanford and Veterans Ad-
ministration Palo Alto Health Care System. For insulin tolerance 
tests (ITTs), mice were fasted overnight. At 9:00 AM of the fol-
lowing day, the mice were weighed, and their baseline blood glu-
cose levels were measured from a tail vein using a glucose meter 
(Bayer Contour). Insulin was injected intraperitoneally at the 
concentration of 0.75 U per kilogram of body weight, and the 
blood glucose level was measured at indicated times. Mice were 
fed after the ITT, and a glucose tolerance test (GTT) was per-
formed 3 days later. Glucose levels prior to and after intraperito-
neal injection of 1 g of glucose per kilogram of body weight were 
measured at the indicated times. 
 Isolation of primary adipocytes and SVCs 
 Adipocytes and SVCs were isolated from visceral and subcuta-
neous WAT from 10-week-old db/db and C57BL/6J mice. To 
obtain enough nuclear proteins for each SRM-MS sample, tissues 
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in the same direction. However, as we also found in the current 
study, the raw values for different peptides from the same protein 
differed by several fold in some cases. Thus, as in ( 10 ), we se-
lected a single representative peptide from each protein and 
used the same peptide for all the samples to do the relative quan-
tifi cation between samples. 
 The heavy and light peptide transitions were measured using 
scheduled SRM-MS. Typically three transitions were measured 
per peptide. All peptides and transitions used in this study are 
listed in supplementary Table 1. SRM-MS traces were analyzed 
using Skyline version 2.5 software (MacCoss Lab, University of 
Washington). The relative protein concentration was then calcu-
lated as the ratio of the sum of the areas of the transitions of the 
endogenous (light) peptide divided by the sum of the areas of 
the transitions of the corresponding heavy peptide. This ratio was 
then log-transformed. Noisy transitions (signal-to-noise <3) were 
not included in the quantifi cation . 
 To ensure the best possible instrument performance, the re-
producibility of the analysis platform (HPLC, source, MS) was 
checked daily using a reference protein mixture consisting of six 
 Bos taurus proteins (MICHROM, USA), and cleaning and calibra-
tion of the instrument was performed as needed. Coeffi cients of 
variation for peak areas and retention times for technical repli-
cates were less than 10% for the same samples run on different 
days and less than 5% for the same samples run on the same day. 
No instrumental drift was observed during sample analysis. 
 Except for RUNX2, which was only measured in the primary 
adipocyte samples, the peptides and proteins presented in this 
paper were detected and measured in all samples and in all rep-
licates. All data, even outliers, were included in the analysis. Normal-
ization was not carried out across samples. Instead, each sample 
was normalized to a control sample prepared in parallel on the 
same day under exactly the same conditions. Each sample and 
the corresponding control sample were then analyzed on the 
mass spectrometer back-to-back on the same day. 
 Immunocytochemistry 
 Following procedures described in ( 9 ), preadipocyte cells 
were plated at 15,000 cells/well and treated as indicated in 96-
well plates (Costar). Cells were fi xed with 3% paraformaldehyde 
in PBS for 30 min. Then the cells were gently washed three times 
with PBS and permeabilized with 0.05% saponin (Sigma #47036), 
blocked with 3% BSA (Sigma #7906), and stained with DAPI 
(1:10,000), anti-PPARG (1:500, Santa Cruz Biotech #sc-7273), 
anti-CEBPA (1:500, Santa Cruz Biotech #sc-61 or #sc-7962), anti-
CEBPB (1:500, Santa Cruz Biotech #sc-150), anti-pAKT (Ser473, 
Cell Signaling #D9E), or BODIPY 493/503, (1   g/ml, Molecular 
Probes #D-3922). Alexa Fluor-514 (#A31558), -555 (#A21429), 
-594 (#A11032), and -647 (#A31571) (1:1,000, Invitrogen) were 
used as secondary antibodies. Images were taken using an Imag-
eXpress Micro XL system (Molecular Devices) and analyzed us-
ing Cell Profi ler software. 
 siRNA synthesis and transfection 
 siRNA for each target protein was made using Giardia dicer as 
described previously ( 9 ). Regions (  500–600 bp) from each 
gene were PCR amplifi ed from a mouse cDNA library, and DNA 
was reverse transcribed using T7 RNA polymerase. dsRNA mole-
cules were then diced with Giardia dicer and purifi ed on glass fi -
ber columns using RNA PureLink RNA lysis buffer and wash 
buffer II (Life Technologies). siRNA concentration was deter-
mined using a NanoDrop spectrophotometer (Thermo Scien-
tifi c), and OP9 cells were transfected in 96-well plates with 20 nM 
siRNA using Lipofectamine RNAiMAX (Life Technologies) in 
MEM  with 20% FBS and 100 U/ml penicillin/streptomycin 
inhibitor cocktail (Roche) to extract the soluble nuclear protein 
fraction. Samples were placed on ice for 15 min followed by gen-
tle shaking every 5 min for an additional 15 min before cen-
trifuging at 16,100  g for 10 min to pellet out the histones and 
DNA. Proteins were precipitated by adding at least 5 vol of ice-
cold acetone and placed at   20°C overnight. Precipitated pro-
teins were centrifuged at 18,000  g for 20 min at 4°C. Protein 
pellets were resuspended in 8 M urea to denature the proteins, 
and were then diluted to 2 M urea with 50 mM ammonium bicar-
bonate. Protein concentrations were measured using the BCA 
protein assay (Thermo Scientifi c). Disulfi de bonds were reduced 
by treating proteins with 10 mM Tris (2-carboxyethyl)phosphine 
hydrochloride for 30 min at 37°C. The free thiol groups on the 
reduced cysteines were alkylated with 15 mM iodoacetamide at 
room temperature for 30 min. The samples were then diluted to 
1 M urea with 50 mM ammonium bicarbonate before adding syn-
thetic heavy peptides (JPT Peptides, Berlin, Germany) for each 
target protein at a ratio of 130 femtomoles per 10   g of total 
protein. Sequencing-grade modifi ed trypsin (Promega) was added 
at a ratio of 1   g per 100   g of protein, and the proteins were 
digested overnight at 37°C. The peptides were acidifi ed to pH 
2–3 with formic acid, desalted on C18 Sep-Pak cartridges (Waters), 
and evaporated on a lyophilizer. The peptides were resolubilized 
in 2% acetonitrile with 0.1% formic acid at a concentration of 
1   g/  l. 
 The purity of the nuclear fraction was verifi ed by using SRM-
MS to monitor control cytosolic and nuclear proteins (supple-
mentary Fig. 1). 
 SRM-based peptide quantifi cation 
 As detailed in ( 10 ), all peptides used in this study were care-
fully selected, verifi ed for robustness and specifi city, and success-
fully applied in a previous study to quantify proteins in OP9 cells, 
an adipocyte cell culture model. Following the procedures de-
scribed in ( 10 ), to quantify proteins, the peptides were separated 
on a Proxeon EASY-nLC Nano-HPLC system (Proxeon, Odense, 
Denmark), and were introduced into a TSQ Vantage triple quad-
rupole mass spectrometer (Thermo Fisher Scientifi c, Bremen, 
Germany) via a Proxeon nanospray ionization source. Peptides 
representing 2   g of total protein were loaded onto a 25 mm × 
0.1 mm C18 trapping column (MICHROM C18, 5   m, 120 Å) 
and a 200 mm × 0.075 mm diameter reverse-phase C18 capillary 
column (Maisch C18, 3   m, 120 Å) and were subjected to a lin-
ear gradient from 0 to 45% acetonitrile over 70 min at a fl ow rate 
of 300 nl/min. 
 To quantify our proteins of interest, we identifi ed prototypic 
peptides and ordered corresponding synthetic heavy labeled 
peptides. The heavy peptides (Spiketides) used as internal stan-
dards were obtained from JPT Peptides and were isotopically la-
beled, ensuring that they coeluted exactly with the endogenous 
peptides and the peak areas could be directly ratioed. To make 
the heavy peptides, the C-terminal amino acid lysine or arginine 
residue was substituted with a heavy version containing 13C and 
15N atoms which resulted in a mass shift of +8 Da for lysine or 
+10 Da for arginine. Heavy peptides containing cysteine residues 
were synthesized with alkylated cysteines. Because the Spiketides 
used as heavy standards were not absolutely quantifi ed, all pro-
tein measurements represent relative, not absolute, abundance. 
 As described in detail in ( 10 ), the heavy peptides served to 
both validate and quantify endogenous peptide transitions. Pep-
tide validation was defi ned by the coelution of both the synthetic 
(heavy) and endogenous (light) peptides, as well as matching 
fragmentation patterns. Also, many peptides were further vali-
dated by carrying out siRNA-mediated depletion experiments. 
Different peptides from the same protein showed similar changes 
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 The heat map in  Fig. 2B shows how protein expression 
levels were altered under the insulin-resistant state in vis-
ceral versus subcutaneous adipocytes in an average of 
three biological replicate experiments. For each experi-
ment, adipocytes were isolated from visceral and subcuta-
neous fat excised from either six C57BL/6J or two db/db 
mice, and thus a total of 18 control animals and 6 db/db 
mice were used to generate the three biological repli-
cates. Values above 0 indicate upregulation, while values 
below 0 indicate downregulation of protein abundances 
in db/db versus C57BL/6J mice. Fold changes with error 
bars are plotted in supplementary Fig. 2. From this data, 
we identifi ed proteins whose abundance was signifi cantly 
altered by insulin resistance in visceral versus subcutane-
ous adipocytes. 
 Almost all of the most differentially abundant proteins in 
visceral versus subcutaneous insulin-resistant adipocytes 
regulate adipogenesis 
 Dysfunctional adipocytes could originate from defects 
in the differentiation process resulting in immature adipo-
cytes that lack proper adipocyte functions. To understand 
whether the proteins whose differential abundance distin-
guished insulin-resistant visceral from subcutaneous WAT 
might be causing defects in differentiation, we carried out 
in vitro differentiation experiments using siRNA knock-
downs of the proteins whose expression levels were the 
most changed in visceral compared with subcutaneous in-
sulin-resistant adipocytes (indicated in red). OP9 cells, a 
mouse cell line that shows many of the same adipogenic 
attributes as preadipocytes in vivo ( 8 ), were transfected 
with siRNA targeting each protein, and differentiated in 
cell culture. Cells were stained for PPARG levels and lipid 
content (using BODIPY) at different time points during 
the 4 days required for OP9 cell differentiation ( Fig. 3A ). 
 Figure 3B, C shows heat maps of fold-changes in PPARG 
and BODIPY intensities for OP9 cells treated with the dif-
ferent siRNA. siRNA targeting YFP and PPARG (marked in 
red) were used as controls. Because PPARG and lipid con-
tent increase over the 4 day time course of differentiation 
( 9 ), both PPARG and BODIPY intensities can be seen to 
increase for the siYFP control ( Fig. 3B, C ). 
 As expected, cells treated with siRNA targeting PPARG, 
the master regulator of adipogenesis, were unable to dif-
ferentiate and failed to accumulate lipid, as shown by a 
lack of BODIPY staining ( Fig. 3C ). The 11 most differentially 
abundant proteins in visceral versus subcutaneous insulin-
resistant adipocytes are marked in red in  Fig. 2B . Figure 
3B and C show that siRNA-mediated depletion of 9 out of 
10 of these proteins had signifi cant effects on adipogene-
sis. In addition, a previous study showed, by siRNA-mediated 
depletion, that Runx2 is a negative regulator of adipogen-
esis ( 10 ). In the experiments shown in  Fig. 3 , depletion of 
Nf  b, Zpf326, Ctnnd1, Hnrnpa2b1, Cebpa, and Nedd4 
decreased both BODIPY and PPARG compared with the 
Yfp control, suggesting that these proteins are positive 
regulators of adipogenesis. On the other hand, depletion 
of Flna, Cstf3, and Mybbp1a increased PPARG expression 
levels and lipid accumulation, suggesting that these proteins 
following the company’s protocol. Primer sequences used to make 
siRNA are listed in supplementary Table 2. 
 RESULTS 
 Development of a targeted proteomics approach to 
obtain quantitative nuclear protein profi les from primary 
mouse adipocytes and SVCs 
 Building on a proteomics approach we developed to 
quantitatively measure the expression of nuclear pro-
teins in adipocyte cell culture models, we now adapted it 
for use in adipocytes and SVCs from different WAT de-
pots in mice ( Fig. 1A ) ( 10 ). WAT was excised from vis-
ceral (epidydimal) and subcutaneous fat depots in mice 
and digested with collagenase to separate out adipocytes 
and SVCs. Cells were broken using mechanical dounc-
ing, and nuclei were isolated from the resulting lysate. To 
isolate nuclei from the primary adipocytes, it was essen-
tial to spin the lysate through a sucrose gradient in order 
to remove the copious fat in the cells. The nuclei were 
broken using a high salt solution, and proteins were ex-
tracted, digested into peptides, and prepared for MS 
analysis. 
 Our approach is based on SRM-MS, which uses a triple 
quadrupole mass spectrometer to target and detect the 
same set of peptides repeatedly in different samples ( Fig. 
1B ). SRM-MS has been shown to be an effective approach 
to quantitate targeted proteins in differentially perturbed 
states ( 10–14 ). In this study, we selected the proteins to be 
measured based on siRNA screening results and published 
literature that supported a role for each protein in adi-
pocyte function ( 15, 16 ). To quantitatively measure the 
abundance of each peptide, heavy peptides corresponding 
to target peptides were spiked into each sample at a known 
concentration. By calculating the ratio of light endoge-
nous peptide to the heavy peptide, the relative abundance 
of each protein was quantifi ed. As shown by the example 
chromatogram of adipocytes isolated from visceral fat 
from a control C57BL/6J mouse ( Fig. 1C ), our method 
has the sensitivity to quantify low abundant proteins, in-
cluding transcription factors such as PPARG, CEBPB, and 
CREB1. Finally, unlike RNA microarrays, SRM-MS quanti-
fi es protein abundance, thereby overcoming discrepan-
cies between RNA and protein levels ( 17 ). The proteins 
and peptides measured in this study are listed in supple-
mentary Table 1. 
 We used our approach to profi le nuclear proteins from 
insulin-resistant adipocytes excised from epididymal vis-
ceral WAT and inguinal subcutaneous WAT from 10-week-
old db/db mice, a commonly used insulin-resistant mouse 
model, and from C57BL/6J (control) male mice. To verify 
that the db/db mice were insulin resistant, we assessed 
systemic insulin sensitivity with GTTs and ITTs ( Fig. 2A ). 
Our results showed that the db/db mice were hyperglyce-
mic and showed delayed and reduced glucose clearance, 
indicating these mice were insulin resistant and glucose 
intolerant. 
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 Fig.  1. Development of a method to quantitatively profi le nuclear protein concentrations in different adipose depots in insulin-resistant 
versus control mice. A: Adipose tissues were digested with collagenase and separated into mature adipocytes and SVCs. Nuclear proteins 
were isolated from cells and digested using trypsin. B: To carry out SRM-MS analysis, the samples were injected into a triple-quadrupole 
mass spectrometer, and the intensity of specifi cally targeted peptides was measured over time. C: Total ion chromatogram of adipocytes 
isolated from C57BL/6J mice. Heavy peptides (internal standards) were added to each sample at a known concentration. The heavy pep-
tides (blue) and light endogenous peptides (red) eluted at the same time. The ratio of the light to heavy peptides was calculated to deter-
mine relative abundance of each peptide. 
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are negative regulators of adipogenesis. As a control, siRNA-
mediated depletion of Mgmt, a protein whose expression 
was not signifi cantly altered by IR in visceral versus sub-
cutaneous adipocytes, did not affect adipogenesis. 
 To determine whether the differentiation capacity of 
SVCs is affected in insulin-resistant visceral and subcuta-
neous tissues, SVCs from the visceral and subcutaneous 
tissue depots of db/db and C57BL/6J mice were differ-
entiated in culture. Although both depots demonstrated 
impaired insulin sensitivity at the cellular level, as deter-
mined by levels of pAKT ( Fig. 4A ), subcutaneous SVCs 
from db/db mice showed no impairment in differentia-
tion compared with control mice, whereas visceral db/db 
SVCs failed to differentiate ( Fig. 4B, C ). This lack of dif-
ferentiation could be partially due to a depletion of the 
preadipocyte pool, because obesity has been shown to 
reduce the number of preadipocytes in adipose tissue, 
for example, by approximately 50% in obese versus lean 
women ( 18 ). However, a preadipocyte pool still exists, 
even in severely obese individuals ( 19 ), and the total lack 
of differentiation of the visceral db/db SVCs suggested 
that the preadipocyte pool was defective in differentia-
tion capacity. 
 A combination of infl ammatory and high-fat stimuli 
best mimics the protein abundance profi le in db/db 
visceral fat 
 To explore what might be causing the defective differ-
entiation in db/db visceral SVCs, we compared nuclear 
protein profiles to protein profiles obtained by apply-
ing different IR-inducing stimuli to OP9 cells. We fi rst 
checked that the different IR-inducing stimuli resulted in 
preadipocytes that were both insulin resistant and defec-
tive in adipogenesis, similar to the characteristics of the 
db/db visceral preadipocytes. OP9 preadipocytes treated 
for 24 h with TNF  , free fatty acids in the form of PA, or 
a combination of TNF  and PA were all insulin resistant, 
as shown by the decreased levels of pAKT ( Fig. 5A ). All of 
these models also showed decreased levels of PPARG and 
CEBPA ( Fig. 5A ), which is consistent with other studies of 
insulin-resistant cells in vitro ( 20 ). To determine whether 
TNF  and PA impede adipogenesis, OP9 cells were dif-
ferentiated in the presence of TNF  , PA, both PA and 
TNF  , or ethanol-BSA complex (control) and assessed 
for adipocyte markers at day 4 ( Fig. 5B ). The results show 
TNF  - and PA-treated cells both inhibited adipogenesis, 
indicated by reduced PPARG expression levels. The higher 
level of BODIPY staining in PA-treated cells compared 
with TNF  is most likely due to the uptake of PA into 
the cells. 
 To compare nuclear protein abundance across these 
varied models of IR, we purifi ed nuclear proteins from the 
insulin-resistant cell culture models and the db/db vis-
ceral SVCs, prepared samples, and analyzed them using 
SRM-MS.  Figure 6 shows a principal component analysis of 
the nuclear protein profi les from the different primary 
cell and cell model experiments. The distinct clustering 
shows that these cell types are all discrete from each other. 
 Fig.  2. Nuclear protein expression levels are changed differently in 
visceral and subcutaneous adipocytes in insulin-resistant mice. A: The 
insulin sensitivities of 10-week-old db/db and C57BL/6J mice were 
determined by ITT and GTT. Blood glucose levels subsequent to intra-
peritoneal injection of insulin or glucose were monitored for the indi-
cated times. Error bars show SEM. The ITT was carried out on nine 
db/db and eight C57 mice. The GTT was carried out on six db/db 
and four C57 mice. * P < 0.05 determined by Student’s  t -test. B: Heat 
map showing changes in protein expression in visceral and subcutane-
ous fat in insulin-resistant mice plotted on a log-scale. Each value rep-
resents the average of three experiments (biological replicates). Each 
experiment used adipose tissue from either six C57BL/6J or two db/
db mice. See supplementary Fig. 2 for bar plots with error bars. The 
proteins that are most differentially expressed between visceral and 
subcutaneous insulin-resistant adipocytes are marked in red. 
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 DISCUSSION 
 Visceral, but not subcutaneous, adipose tissue mass is 
highly correlated with IR and metabolic diseases ( 5, 6 ). 
Previous studies have identifi ed intrinsic differences among 
preadipocyte populations isolated from different fat de-
pots using several different measurement techniques ( 21–
23 ). Here we developed a targeted proteomics method 
using SRM-MS to quantitatively measure nuclear protein 
abundances in mature adipose tissue excised from mice, 
and have applied this method to identify differentially 
Interestingly, the db/db visceral SVC population corre-
lates most closely with the OP9 cells treated with PA and 
TNF  . The fold changes for the measured nuclear pro-
teins in cells treated with PA and TNF  compared with 
control and db/db visceral SVCs are shown in supplemen-
tary Figs. 3–5. Examining how each protein contributes to 
the fi rst two principal components (plotted in supplemen-
tary Fig. 6) shows the two proteins that contributed most 
to the fi rst principal component were CSTF3 and FLNA, 
both strong negative regulators of adipogenesis, as shown 
in the siRNA results in  Fig. 3B, C . 
 Fig.  3. The proteins that are most differentially expressed between insulin-resistant visceral and subcuta-
neous fat affect adipogenesis. A: OP9 cells were differentiated over 4 days in culture following a standard 
protocol. Images for BODIPY- and PPARG-stained cells are shown at different time points during differentia-
tion. Scale bar represents 40   m. B, C: OP9 cells were transfected on day 0 with the indicated siRNA and 
differentiated in culture. siRNA targeting Yfp was used as a negative control, and siRNA targeting Pparg was 
used as a positive control. B: Cells were fi xed at days 1–4 during differentiation and stained for PPARG inten-
sity. Each datapoint (square) on the heatmap represents the average PPARG intensity in   15,000 cells trans-
fected with the indicated target siRNA (siTarget) divided by the average PPARG intensity in   15,000 cells 
transfected with control siRNA targeting YFP and fi xed at day 1 or 24 h after transfection (siYFP 1 ). C: Cells 
were fi xed at days 3 and 4, and stained for BODIPY to assess lipid content. Each datapoint on the heatmap 
represents the average BODIPY intensity in   15,000 cells transfected with the indicated target siRNA (siTar-
get) divided by the average BODIPY intensity in   15,000 cells transfected with control siRNA targeting YFP 
and fi xed at day 3 or 72 h after transfection (siYFP 3 ). 
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( Fig. 3 ), such as FLNA, CSTF3, and MYBBP1A, were con-
sistently increased in visceral versus subcutaneous db/db 
adipocytes . On the other hand, the proteins that we found 
to be the most decreased in visceral versus subcutaneous 
db/db adipocytes, such as HNRNPA2B1, NEDD4, CEBPA, 
and PPARG, were positive regulators of adipogenesis. These 
results suggest that a key difference between visceral and 
subcutaneous insulin-resistant (db/db) adipocytes is defec-
tive differentiation. 
 The likelihood of defective differentiation being a main 
difference between visceral and subcutaneous insulin-
resistant adipose tissue was further supported by a reduced 
expressed proteins between visceral and subcutaneous 
adipocytes from db/db insulin-resistant mice and C57BL/6J 
control mice. We showed that nuclear protein abundance 
levels are not uniformly altered in subcutaneous and vis-
ceral adipocytes in insulin-resistant db/db mice, and that 
many of the most differentially expressed proteins affected 
adipogenesis. This observation is in line with previous 
studies in which gene expression levels of adipogenic 
genes such as Pparg and Cebpa were decreased in IR in 
both humans and mice ( 24, 25 ). 
 Here we observed that proteins we found to be negative 
regulators of adipogenesis from our siRNA experiments 
 Fig.  4. Immunocytochemistry analysis indicates that visceral, but not subcutaneous, SVCs are defective in adipogenesis. A: SVCs isolated 
from visceral and subcutaneous adipose tissues of db/db and C57BL/6J mice were cultured and analyzed by immunocytochemistry using 
anti-pAKT. Intensity levels in response to insulin were quantifi ed and plotted in a bar graph. For each biological replicate,   5,000 cells were 
analyzed. B: SVCs from visceral and subcutaneous adipose tissues were differentiated over 8 days in culture. Cells were stained with BODIPY 
and Hoescht. C: On day 8, cells were also stained for PPARG and CEBPA, and intensities were quantifi ed. For each biological replicate, 
  8,000 cells were analyzed. Error bars indicate SEM (n = 3 biological replicates). * P < 0.05 determined by the Student’s  t -test. 
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during differentiation. However, because insulin signaling 
pathways involve many membrane proteins and cytosolic 
proteins, it will be of interest to study changes in proteins 
in other cellular compartments in the future. Several stud-
ies have profi led primary adipocytes from different fat de-
pots using microarrays, but the SRM-MS-based method we 
differentiation capacity of visceral SVCs isolated from 
db/db mice compared with the SVCs isolated from C57BL/6J 
control mice, while subcutaneous SVCs from db/db mice 
retained their capacity to differentiate in vitro. Previous 
clinical studies have shown decreased adipogenesis in sub-
cutaneous adipose tissue of insulin-resistant patients, but 
this observation was not made with our subcutaneous SVCs 
isolated from db/db mice ( 26 ). In summary, our results 
suggest that insulin-resistant visceral adipose tissue is de-
fective in differentiation compared with insulin-resistant 
subcutaneous adipose tissue. This defective differentiation 
would result in a lack of mature adipocytes that are capa-
ble of uptaking glucose in response to insulin, possibly ex-
plaining why visceral tissue is more closely associated with 
systemic IR. 
 We also observed increased levels of pro-infl ammatory 
proteins such as NF  B1, as well as CEBPB, in visceral db/
db adipocytes. The increased levels of both infl ammation 
and CEBPB have been observed in many other studies in 
both cell culture and in animals that show TNF  -induced 
infl ammation and IR ( 20, 27, 28 ). To start to understand 
what might be causing the defective adipogenesis observed 
in the db/db visceral adipose tissue, we used our SRM-MS 
method to compare the abundance of a group of nuclear 
proteins in different adipocytes from db/db mice to the 
nuclear protein profi les observed in different cell culture 
models of IR. We showed that the nuclear protein profi le 
of visceral SVCs correlates more with the nuclear protein 
profi le of an in vitro model of insulin-resistant cells treated 
with both TNF  and PA, suggesting that the defective adi-
pogenesis in db/db visceral tissue could be due to a com-
bination of inputs from infl ammation and fatty acids. 
 This study focused on quantifying transcription factors 
and chromatin remodeling proteins due to their importance 
 Fig.  5. TNF  and PA induce IR and defective dif-
ferentiation in cell culture. A: OP9 preadipocytes 
were treated with TNF  , PA, or both TNF  and PA for 
24 h. Water was used as a control for TNF  , and BSA-
ethanol (BSA) was used as a control for PA and 
PA+TNF  treatments. Insulin sensitivity was deter-
mined by staining cells for pAKT by immunocyto-
chemistry. Intensities were quantifi ed and plotted on 
a bar graph. B: To determine the effect of different 
treatments on differentiation, OP9 cells were differ-
entiated in the presence of TNF  , PA, or both TNF  
and PA. Cells were stained for PPARG, CEBPΑ, 
BODIPY, and pAKT on day 4, and intensities were 
quantifi ed. Error bars indicate SEM (n = 3 biological 
replicates). For each biological replicate,   15,000 
cells were analyzed. * P < 0.05 determined by the Stu-
dent’s  t -test. 
 Fig.  6. Principal component analysis shows that the protein pro-
fi les of insulin-resistant primary adipocytes, primary SVCs, and 
OP9 cell culture models are distinct based on changes in protein 
abundances. The proximity of the clusters indicates how similar 
the samples are, and interestingly, the protein profi le of visceral 
SVCs most closely matches that of OP9 preadipocytes treated with 
both PA and TNF  . Supplementary Fig. 6 shows how the different 
proteins contribute to the fi rst two principal components. 
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developed has the advantage of profi ling at the protein 
level, which is the most direct approach to assess the state 
of the cell because the expression level and molecular form 
of proteins is an integration of genomic and environmen-
tal factors, and developmental, metabolic, and homeostatic 
processes. Because proteins mediate cell activities down-
stream of mRNA, it is essential that protein levels are quanti-
fi ed accurately to characterize molecular differences among 
different cell populations. Also, many studies have now 
shown that mRNA expression matches very poorly with 
protein expression because of variations in protein half-lives, 
differences in the degree of posttranslational modifi cations, 
and other factors ( 17, 29, 30 ). 
 The SRM-MS method we developed can be applied to 
profi le adipose tissues from other animal models and can 
be used to identify important biomarkers that are com-
monly associated with impaired differentiation or IR. For 
instance, IR can be observed in high-fat diet-fed mice, 
aged mice, or different genetic mouse models. It is likely 
that insulin-resistant adipocytes from different animal 
models have different molecular features. Using SRM-MS, 
it will be possible to determine how these cells differ, or to 
study the effects of drugs and small molecules on the ex-
pression levels of several tens to hundreds of proteins 
from a single sample. These future studies will advance 
our understanding of molecular mechanisms underlying 
the development of IR, and will aid in the development of 
therapeutics to help prevent more severe diseases. Finally, 
our protocols and approach can easily be extended to hu-
mans and other organisms, and to other tissues. 
 Here we have introduced a method to quantitatively 
measure nuclear protein abundances from different adi-
pose depots in different mouse models and have applied it 
to control C57BL/6J and insulin-resistant db/db mice. 
Whereas db/db mice are commonly used as a model for 
IR, it is plausible that leptin defi ciency might be contributing 
to the differences we observed. In the future, to distinguish 
between differences due to IR versus leptin defi ciency, it 
would be interesting to apply our method to other mouse 
models of IR, such as diet-induced obesity. 
 In summary, this study describes a novel protein profi l-
ing method that we developed to quantify large numbers 
of key, but low-abundant, nuclear proteins in primary fat 
cells which regulate whole body metabolism and play a 
central role in metabolic disease. We applied our method 
to quantitate and compare for the fi rst time the endoge-
nous abundance of more than 40 transcription factors, 
chromatin-remodeling, and other key nuclear proteins in 
different adipose depots in insulin-resistant mice without 
needing antibodies and requiring only 2   g of protein to 
analyze each sample, approximately 20 times less than is 
required for a Western blot lane. This method allowed us 
to uncover new candidate proteins involved in IR that 
could be potential drug targets, as well as to understand 
fundamental differences between insulin-resistant and in-
sulin-sensitive adipocytes in vivo at the protein level. This 
method will likely have broad utility in understanding the 
origin of adipocyte dysfunction in other mouse models of 
IR, as well as in humans .  
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